Metformin effects on respiratory and metabolic outcomes in asthma and metabolic syndrome: a double-blind, randomized, placebo-controlled clinical trial
Our findings demonstrate that metformin administration in patients with concurrent asthma and MetS could lead to substantial enhancements in ACT score, FEV<sub>1</sub>, and FVC.
Authors
- Alireza Kashefizadeh (ORCID: https://orcid.org/0000-0001-7997-0365)
- Alistair Bahar (ORCID: https://orcid.org/0000-0002-3254-6230)
- Fatemeh Hajimohammadi (ORCID: https://orcid.org/0000-0002-3970-2232)
- Hossein Mehravaran (ORCID: https://orcid.org/0000-0001-8409-1736)
- Reza Alizadeh‐Navaei (ORCID: https://orcid.org/0000-0003-0580-000X)
- Erfan Ghadirzadeh (ORCID: https://orcid.org/0000-0002-3903-0464)
- Jamshid Yazdani Charati (ORCID: https://orcid.org/0000-0002-4721-225X)
- Zahra Kashi (ORCID: https://orcid.org/0000-0002-4683-1323)
- Mobina Gheibi
- Masoud Aliyali (ORCID: https://orcid.org/0009-0009-2582-0068)
- Fatemeh Varshoei (ORCID: https://orcid.org/0000-0001-5083-0115)
Institutions
- Shahid Beheshti University of Medical Sciences (IR)
- Mazandaran University of Medical Sciences (IR)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-07-18
- DOI
- https://doi.org/10.1097/ms9.0000000000003552
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00